ForMor Challenges FDA On Own-Label Supplement GMP Stance
This article was originally published in The Tan Sheet
ForMor contests a warning letter from FDA stating that as an own-label distributor, the firm is subject to both packager and labeler GMP requirements. The firm says it is only a “holder” of finished products and FDA bases its warning on the GMP rule preamble, not the actual rule.
You may also be interested in...
Revival Products’ GMP deficiencies concerned work and training of its quality control staff, including failing to document review and approval for release of any packaged and labeled supplement for distribution and destroying returned products without review.
FDA loses patience with Confidence; Warning underscores interest in concussion claims; Nestle invests in ready-to-drink supplement plant; Garlic supplement makes drug claims; Skin care claims enter drug realm;; more In Brief.
FDA has begun holding own-label dietary supplement marketers responsible for their contract manufacturers’ violations of good manufacturing practices.